Schedule 13D ownership disclosure

IMAGO BIOSCIENCES INC

Security class unavailable · CUSIP: 45250K107

Event date: 2022-03-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-22-093864
Form type
SC 13D/A
Filer
Clarus Lifesciences III, L.P.
CIK
CIK 1597143
Filed
Apr 01, 2022
Reporting period
Mar 30, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub